Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 11 articles:
HTML format



Single Articles


    April 2022
  1. JAFFE S
    Medicare covers new Alzheimer's drug, but there is a catch.
    Lancet. 2022;399:1585.
    PubMed    


    September 2021
  2. SCHELTENS P
    Responding to responsive behaviour in Alzheimer's disease - Author's reply.
    Lancet. 2021;398:842.
    PubMed    


  3. O'NEILL D, Kennelly S
    Responding to responsive behaviour in Alzheimer's disease.
    Lancet. 2021;398:842.
    PubMed    


    July 2021
  4. JAFFE S
    US FDA defends approval of Alzheimer's disease drug.
    Lancet. 2021;398:12.
    PubMed    


    March 2021
  5. SCHELTENS P, De Strooper B, Kivipelto M, Holstege H, et al
    Alzheimer's disease.
    Lancet. 2021 Mar 2. pii: S0140-6736(20)32205.
    PubMed     Abstract available


    February 2021
  6. SIVA N
    New global initiative to tackle Alzheimer's disease.
    Lancet. 2021;397:568-569.
    PubMed    


    June 2020
  7. FORTEA J, Vilaplana E, Carmona-Iragui M, Benejam B, et al
    Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Lancet. 2020;395:1988-1997.
    PubMed     Abstract available


  8. HEAD E, Ances B
    Biomarkers in Down syndrome can help us understand Alzheimer's disease.
    Lancet. 2020;395:1951-1953.
    PubMed    


    February 2020
  9. SEN A, Jette N, Husain M, Sander JW, et al
    Epilepsy in older people.
    Lancet. 2020;395:735-748.
    PubMed     Abstract available


  10. WATTS G
    Giovanna Mallucci: redefining neurodegeneration.
    Lancet. 2020;395:486.
    PubMed    


    September 2019
  11. KEUSS SE, Bowen J, Schott JM
    Looking beyond the eyes: visual impairment in posterior cortical atrophy.
    Lancet. 2019;394:1055.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: